Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China · Delayed Price · Currency is CNY 11.53
+0.03 (0.26%)
Feb 4, 2026, 3:00 PM CST
SHA:603811 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 226.35 | 200.7 | 162.9 | 161.58 | 170.8 | 165.14 |
Depreciation & Amortization | 95.27 | 95.27 | 78.12 | 62.37 | 55.04 | 47.87 |
Other Amortization | 1.58 | 1.58 | 0.67 | 0.85 | 0.79 | 0.92 |
Loss (Gain) From Sale of Assets | -0.29 | -0.29 | 0 | -0.06 | 0.45 | -0 |
Asset Writedown & Restructuring Costs | 24 | 24 | 7.47 | 2.82 | -7.27 | 8.12 |
Loss (Gain) From Sale of Investments | -43.39 | -43.39 | -58.14 | -46.68 | -30.53 | -22.24 |
Provision & Write-off of Bad Debts | -2.31 | -2.31 | 0.94 | 0.06 | 0.52 | 1.09 |
Other Operating Activities | 83.03 | 16.71 | 20.54 | 18.25 | 3.91 | 11.26 |
Change in Accounts Receivable | -19.24 | -19.24 | -30.46 | -63.82 | -33.47 | -42.41 |
Change in Inventory | -20.83 | -20.83 | -12.03 | -3.23 | -2.11 | -27.05 |
Change in Accounts Payable | 24.39 | 24.39 | 15.44 | 31.65 | -14.67 | 36.55 |
Change in Other Net Operating Assets | -68.88 | -68.88 | - | - | -1.2 | - |
Operating Cash Flow | 297.69 | 205.72 | 194.78 | 165.94 | 143.49 | 177.81 |
Operating Cash Flow Growth | 69.96% | 5.61% | 17.38% | 15.65% | -19.30% | -1.77% |
Capital Expenditures | -21.74 | -59.89 | -70.85 | -252.85 | -134.11 | -143.67 |
Sale of Property, Plant & Equipment | 13.97 | 77.1 | 0 | 0.22 | 0.42 | 0.14 |
Cash Acquisitions | - | - | - | - | -2.26 | - |
Divestitures | -0.03 | -0.03 | - | - | - | - |
Investment in Securities | 9 | 9 | 11.25 | - | 24.4 | -158.38 |
Other Investing Activities | 2.25 | - | - | 11.25 | 13.34 | - |
Investing Cash Flow | 3.45 | 26.18 | -59.6 | -241.38 | -101.14 | -301.91 |
Long-Term Debt Issued | - | 177.8 | 295.2 | 562.13 | 92.46 | 310.31 |
Total Debt Issued | 115 | 177.8 | 295.2 | 562.13 | 92.46 | 310.31 |
Short-Term Debt Repaid | - | - | - | - | -1.48 | -4.3 |
Long-Term Debt Repaid | - | -389.83 | -278.73 | -286.1 | -61.38 | -200.3 |
Total Debt Repaid | -309.38 | -389.83 | -278.73 | -286.1 | -62.86 | -204.6 |
Net Debt Issued (Repaid) | -194.37 | -212.02 | 16.47 | 276.03 | 29.6 | 105.71 |
Issuance of Common Stock | 48.29 | - | - | - | - | - |
Repurchase of Common Stock | -67.26 | -67.26 | - | - | - | - |
Common Dividends Paid | -85.15 | -76.7 | -73.95 | -68.78 | -62.87 | -52.38 |
Other Financing Activities | -8.85 | - | 2.1 | - | 0.59 | 3.45 |
Financing Cash Flow | -307.35 | -355.98 | -55.38 | 207.25 | -32.67 | 56.78 |
Foreign Exchange Rate Adjustments | -0.16 | 0.29 | 0.03 | 0.2 | -0.54 | -0.77 |
Net Cash Flow | -6.37 | -123.8 | 79.83 | 132.01 | 9.14 | -68.1 |
Free Cash Flow | 275.95 | 145.83 | 123.93 | -86.92 | 9.38 | 34.13 |
Free Cash Flow Growth | 164.53% | 17.67% | - | - | -72.52% | - |
Free Cash Flow Margin | 34.89% | 20.41% | 18.45% | -13.27% | 1.35% | 4.50% |
Free Cash Flow Per Share | 0.85 | 0.44 | 0.38 | -0.26 | 0.03 | 0.10 |
Cash Interest Paid | - | - | - | - | 0.06 | 0.38 |
Cash Income Tax Paid | 105.23 | 84.61 | 35.37 | 63.86 | 96.13 | 78.39 |
Levered Free Cash Flow | 248.16 | 94.17 | 122.69 | -134.99 | -6.24 | -33.18 |
Unlevered Free Cash Flow | 251.77 | 101.1 | 132.23 | -129.28 | -3.41 | -30.08 |
Change in Working Capital | -86.55 | -86.55 | -17.72 | -33.26 | -50.22 | -34.36 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.